GW Pharmaceuticals
| Use attributes for filter ! | |
| Stock price | GWPRF |
|---|---|
| Disclaimer | |
| Headquarters | Cambridge |
| United Kingdom | |
| Ceo | Justin Gover |
| Founders | Geoffrey W. Guy |
| Brian Whittle | |
| Subsidiaries | Greenwich Biosciences, Inc |
| GW Research Ltd | |
| Cannabinoid Research Institute Limited | |
| GW Pharma Limited | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 952056 |
About GW Pharmaceuticals
GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country.
